Cargando…

Xiyanping Plus Azithromycin Chemotherapy in Pediatric Patients with Mycoplasma pneumoniae Pneumonia: A Systematic Review and Meta-Analysis of Efficacy and Safety

BACKGROUND: Xiyanping injection (XYP) is a well-known Chinese medicinal preparation reputed as a most effective alternative to antibiotics. XYP has been widely used in combination therapies to treat various infectious diseases, among which XYP plus azithromycin (AZM) chemotherapy is often used for t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qiao, Li, Zhi-Yong, Zhang, Jie, Guo, Wen-Na, Xu, Xiao-Meng, Sun, Fa-Xin, Xu, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735175/ https://www.ncbi.nlm.nih.gov/pubmed/31558910 http://dx.doi.org/10.1155/2019/2346583

Ejemplares similares

Comparison of azithromycin and erythromycin in the treatment of mycoplasma pneumonia in children
por: Han, Rui, et al.
Publicado: (2020)

A retrospective study of azithromycin and ceftizoxime for the management of children with Mycoplasma pneumoniae pneumonia
por: Han, Li-ping, et al.
Publicado: (2021)

Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients
por: Ishiguro, Nobuhisa, et al.
Publicado: (2017)

The Effect of Azithromycin Combined with Palm Massage on Pulmonary Function of Children with Mycoplasma Pneumonia
por: Li, Haiyan, et al.
Publicado: (2022)

Efficacy of Azithromycin plus Glucocorticoid Adjuvant Therapy on Serum Inflammatory Factor Levels and Incidence of Adverse Reactions in Children with Mycoplasma Pneumonia
por: Cao, Yingdong, et al.
Publicado: (2022)

Immunological Features of Pediatric Interstitial Pneumonia Due to Mycoplasma pneumoniae
por: Xu, Xuefeng, et al.
Publicado: (2021)

High Mycoplasma pneumoniae loads and persistent long-term Mycoplasma pneumoniae DNA in lower airway associated with severity of pediatric Mycoplasma pneumoniae pneumonia
por: Liu, Jinrong, et al.
Publicado: (2019)

Tigecycline in the treatment of fulminant Mycoplasma pneumoniae pneumonia non-responsive to azithromycin and fluoroquinolone: A case report
por: Yuan, Xin, et al.
Publicado: (2020)

Efficacy and safety of Xiyanping for COVID-2019: A protocol for systematic review and meta-analysis
por: Zhou, Hui, et al.
Publicado: (2020)

Mycoplasma pneumoniae pneumonia with pulmonary embolism: A study on pediatric cases in Jilin province of China
por: Sheng, Chu-Qiao, et al.
Publicado: (2021)

Xiao'er Xiaoji Zhike Oral Liquid Combined with Azithromycin for Mycoplasma pneumoniae Pneumonia in Children: A Systematic Review and Meta-Analysis
por: Zhang, Gui-Min, et al.
Publicado: (2020)

The Pharmacological Mechanism of Xiyanping Injection for the Treatment of Novel Coronavirus Pneumonia (COVID-19): Based on Network Pharmacology Strategy
por: Xia, Liang-jing, et al.
Publicado: (2022)

Control of a Mycoplasma pneumoniae Outbreak in an Institutional Setting Using Azithromycin Prophylaxis
por: Gdalevich, Michael, et al.
Publicado: (2018)

Changes in coagulation markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for Mycoplasma severity
por: Li, Yong-tao, et al.
Publicado: (2023)

Correlation between Mycoplasma pneumoniae drug resistance and clinical characteristics in bronchoalveolar lavage fluid of children with refractory Mycoplasma pneumoniae pneumonia
por: Zhan, Xiao-Wen, et al.
Publicado: (2022)

Efficacy of Jiedu Pingsou Decoction Combined with Azithromycin in the Treatment of Children with Mycoplasma Pneumonia and Its Effects on Inflammatory Factors and Immune Function
por: Lin, Shaoli, et al.
Publicado: (2022)

Pathogenic Analysis of the Bronchoalveolar Lavage Fluid Samples With Pediatric Refractory Mycoplasma pneumoniae Pneumonia
por: Zhao, Fei, et al.
Publicado: (2020)

Retracted: The Effect of Azithromycin Combined with Palm Massage on Pulmonary Function of Children with Mycoplasma Pneumonia
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

The timing of azithromycin treatment is not associated with the clinical prognosis of childhood Mycoplasma pneumoniae pneumonia in high macrolide-resistant prevalence settings
por: Yang, Dehua, et al.
Publicado: (2018)

Cost-Effectiveness Analysis of Xiyanping Injection (Andrographolide Sulfonate) for Treatment of Adult Community Acquired Pneumonia: A Retrospective, Propensity Score-Matched Cohort Study
por: Shi, Honghao, et al.
Publicado: (2019)

Low Bacterial Co-infection Invalidates the Early Use of Non-anti-Mycoplasma pneumoniae Antibiotics in Pediatric Refractory Mycoplasma pneumoniae Pneumonia Patients
por: Liu, Jin-Rong, et al.
Publicado: (2018)

Analysis of clinical value of CT in the diagnosis of pediatric pneumonia and mycoplasma pneumonia
por: GONG, LIANG, et al.
Publicado: (2016)

Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia
por: Chen, Yu-Chin, et al.
Publicado: (2020)

Traditional Chinese Medicine Oral Liquids Combined With Azithromycin for Mycoplasma pneumoniae Pneumonia in Children: A Bayesian Network Meta-Analysis
por: Chen, Zhe, et al.
Publicado: (2021)

Mycoplasma pneumoniae and Adenovirus Coinfection Cause Pediatric Severe Community-Acquired Pneumonia
por: Li, Fei, et al.
Publicado: (2022)

Thromboembolic complications of Mycoplasma pneumoniae pneumonia in children
por: Chen, Lanqin, et al.
Publicado: (2023)

Mycoplasma pneumoniae pneumonia in children
por: Youn, You-Sook, et al.
Publicado: (2012)

The History of Mycoplasma pneumoniae Pneumonia
por: Saraya, Takeshi
Publicado: (2016)

Respiratory microbiota imbalance in children with Mycoplasma pneumoniae pneumonia
por: Wang, Yacui, et al.
Publicado: (2023)

Shuanghuanglian oral preparations combined with azithromycin for treatment of Mycoplasma pneumoniae pneumonia in Asian children: A systematic review and meta-analysis of randomized controlled trials
por: Peng, Yingying, et al.
Publicado: (2021)

Expression of Serum miR-155 in Children with Mycoplasma pneumoniae Pneumonia and Its Role in Immunity to Mycoplasma pneumoniae
por: Jin, Yue, et al.
Publicado: (2021)

Clinical characteristics of 14 pediatric mycoplasma pneumoniae pneumonia associated thrombosis: a retrospective study
por: Fu, Y., et al.
Publicado: (2023)

Associations of radiological features in Mycoplasma pneumoniae pneumonia
por: Guo, Qi, et al.
Publicado: (2014)

Comparative efficacy of Chinese herbal injections combined with azithromycin for mycoplasma pneumonia in children: A Bayesian network meta‐analysis of randomized controlled trials
por: Duan, Xiaojiao, et al.
Publicado: (2019)

Clinical significance of different bacterial load of Mycoplasma pneumoniae in patients with Mycoplasma pneumoniae pneumonia
por: Jiang, Wujun, et al.
Publicado: (2013)

Differences of clinical features and prognosis between Mycoplasma pneumoniae necrotizing pneumonia and non-Mycoplasma pneumoniae necrotizing pneumonia in children
por: Yang, Beilei, et al.
Publicado: (2021)

Clinical features and “early” corticosteroid treatment outcome of pediatric mycoplasma pneumoniae pneumonia
por: Liu, Jinrong, et al.
Publicado: (2023)

Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children’s hospital
por: Liu, Jinrong, et al.
Publicado: (2020)

Impact of Epstein-Barr virus coinfection in Mycoplasma pneumoniae pneumonia
por: Xu, Yingchun, et al.
Publicado: (2020)

Immune response plays a role in Mycoplasma pneumoniae pneumonia
por: Zhu, Yifan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2qsh0tdfaj4h24uvsdj8gargrm